Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
14.00
-0.03 (-0.21%)
At close: Jul 31, 2026, 4:00 PM EDT
13.73
-0.27 (-1.93%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Generate Biomedicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $30 | Buy | Reiterates | $30 | +114.29% | Jun 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +57.14% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $24 | Buy | Reiterates | $24 | +71.43% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +78.57% | May 8, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $26 | Buy | Maintains | $26 | +85.71% | Apr 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |